Galera Therapeutics, Inc. (GRTX) has 6 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 5, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 5, 2026 filed Aug. 3, 2026 | Sorensen Mel President and CEO | $0 | 30,975 | −100% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | LOKAY KEVIN G Director | $0 | 240 | — | No | |
|
|
||||||
| Aug. 5, 2026 filed May 15, 2026 | CHANG NANCY T Director | $0 | 709,884 | — | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | Alleva Lawrence M Director | $0 | 291 | −100% | No | |
|
|
||||||
| Aug. 5, 2026 filed Aug. 3, 2026 | Sussman Joel F. Chief Accounting Officer | $0 | 10,000 | — | No | |
|
|
||||||
Showing the 5 most recent of 6 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free